olaparib and Body-Weight

olaparib has been researched along with Body-Weight* in 1 studies

Other Studies

1 other study(ies) available for olaparib and Body-Weight

Article	Year
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors. European journal of medicinal chemistry, 2018, Feb-10, Volume: 145 Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzimidazoles; Body Weight; Cell Line; Cell Proliferation; Cricetulus; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship; Thermodynamics	2018

Article

Year

Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors.

European journal of medicinal chemistry, 2018, Feb-10, Volume: 145

Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzimidazoles; Body Weight; Cell Line; Cell Proliferation; Cricetulus; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship; Thermodynamics

2018